HUP0202776A2 - (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására - Google Patents

(+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására

Info

Publication number
HUP0202776A2
HUP0202776A2 HU0202776A HUP0202776A HUP0202776A2 HU P0202776 A2 HUP0202776 A2 HU P0202776A2 HU 0202776 A HU0202776 A HU 0202776A HU P0202776 A HUP0202776 A HU P0202776A HU P0202776 A2 HUP0202776 A2 HU P0202776A2
Authority
HU
Hungary
Prior art keywords
desmethyl
tramadol
demethyltramadol
mono
urinary incontinence
Prior art date
Application number
HU0202776A
Other languages
English (en)
Inventor
Thomas Christoph
Elmar Friderichs
Original Assignee
Grünenthal GmbH.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19947747A external-priority patent/DE19947747A1/de
Priority claimed from DE20002943U external-priority patent/DE20002943U1/de
Application filed by Grünenthal GmbH. filed Critical Grünenthal GmbH.
Publication of HUP0202776A2 publication Critical patent/HUP0202776A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány tárgya (+)-tramadol, illetve 0-demetil-tramadol, különösen(+)-0-demetil-tramadol, 0-demetil-N-mono-demetiltramadol, különösen(+)-0-demetil-N-mono-demetil-tramadol felhasználása a szabad bázisés/vagy gyógyászatilag alkalmas sók formájában megnövekedett vizelésiinger, illetve vizeletinkontinencia kezelésére alkalmas gyógyászatikészítmények előállítására. A találmány továbbá a megfelelőgyógyászati készítményekre, valamint megnövekedett vizelési inger,illetve vizeletinkontinencia kezelési eljárására vonatkozik. Ó
HU0202776A 1999-10-05 2000-09-27 (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására HUP0202776A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19947747A DE19947747A1 (de) 1999-10-05 1999-10-05 Verwendung von (+)-Tramadol, O-Demethyltramadol bzw. (+)-O-Demethyltramadol zur Therapie der Harninkontinenz
DE20002943U DE20002943U1 (de) 2000-02-21 2000-02-21 Arzneimittel enthaltend O-desmethyl-N-mono-desmethyl-tramadol
PCT/EP2000/009420 WO2001024783A2 (de) 1999-10-05 2000-09-27 Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz

Publications (1)

Publication Number Publication Date
HUP0202776A2 true HUP0202776A2 (hu) 2003-02-28

Family

ID=26055167

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202776A HUP0202776A2 (hu) 1999-10-05 2000-09-27 (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására

Country Status (13)

Country Link
US (1) US6660774B2 (hu)
EP (1) EP1217998B1 (hu)
JP (1) JP5477881B2 (hu)
AT (1) ATE368455T1 (hu)
AU (1) AU7907600A (hu)
CA (1) CA2386381A1 (hu)
DE (1) DE50014532D1 (hu)
ES (1) ES2291223T3 (hu)
HK (1) HK1047707A1 (hu)
HU (1) HUP0202776A2 (hu)
MX (1) MXPA02003491A (hu)
PE (1) PE20010623A1 (hu)
WO (1) WO2001024783A2 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
FR2815691B1 (fr) * 2000-10-20 2003-08-15 Valois Sa Bille de clapet
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224107A1 (de) * 2002-05-29 2003-12-11 Gruenenthal Gmbh Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
JP4059259B2 (ja) 2005-06-30 2008-03-12 ヤマハ株式会社 スピーカシステムおよびスピーカエンクロージャー
JPWO2007018234A1 (ja) * 2005-08-10 2009-02-19 日本新薬株式会社 尿道内圧上昇作用剤
CN101242856A (zh) 2005-09-09 2008-08-13 莱博法姆公司 持续药物释放的组合物
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US11000488B2 (en) 2019-03-22 2021-05-11 Syntrix Biosystems Inc. Treating pain using desmetramadol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226624T3 (de) 1991-09-06 2009-11-05 Ortho-Mcneil Pharmaceutical, Inc. Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
NO300197B1 (no) 1991-09-06 1997-04-28 Mcneilab Inc Preparater omfattende tramadol og et opioid
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE69826113T2 (de) * 1997-03-11 2005-01-20 Arakis Ltd., Saffron Walden R- und s- enantiomere getrennteteile enthaltende dosierungsformen
DE19712398A1 (de) * 1997-03-25 1998-10-01 Gruenenthal Gmbh Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel
WO1998046216A1 (fr) * 1997-04-11 1998-10-22 Nippon Shinyaku Co., Ltd. Traitements des mictions frequentes et de l'incontinence urinaire
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles

Also Published As

Publication number Publication date
DE50014532D1 (de) 2007-09-13
JP2003510350A (ja) 2003-03-18
WO2001024783A3 (de) 2002-02-28
ATE368455T1 (de) 2007-08-15
US20030069314A1 (en) 2003-04-10
JP5477881B2 (ja) 2014-04-23
ES2291223T3 (es) 2008-03-01
CA2386381A1 (en) 2001-04-12
EP1217998A2 (de) 2002-07-03
PE20010623A1 (es) 2001-07-07
MXPA02003491A (es) 2002-08-20
HK1047707A1 (zh) 2003-03-07
AU7907600A (en) 2001-05-10
US6660774B2 (en) 2003-12-09
EP1217998B1 (de) 2007-08-01
WO2001024783A2 (de) 2001-04-12

Similar Documents

Publication Publication Date Title
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
GB0001309D0 (en) Valve arrangement
IL206830A (en) Use of an integrin-containing antagonist of the alpha 1 subunit - of the integrin to prepare a drug for the treatment of osteoporosis
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
ATE371665T1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
MY164077A (en) Compositions and uses of et743 for treating cancer
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
UA66856C2 (uk) Тієнопіримідини, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
MXPA02009176A (es) Tratamiento combinado con factor de crecimiento de queratinocito e inhibidor del factor de crecimiento epidermico.
HUP0302984A2 (hu) Buprenorphin felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
AU2001246388A1 (en) Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
SE0101256D0 (sv) Treatment of low back pain
AU2002236587A1 (en) Compositions for adhesion prevention
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
MXPA04005265A (es) Uso de derivados del acido 4-oxobutanoico para el tratamiento contra inflamacion.
WO2004045490A3 (en) Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
UA37653A (uk) Спосіб лікування апендикулярного інфільтрату у дітей